BVMF/C1OO34 (BVMF/C1OO34)

Brazil Stock Exchange: BVMF/C1OO34 · BRL

R$30.7

+0.27 (+0.9%)· Recorded snapshot

Market cap	60.7B
Revenue (ttm)	21.5B
Net income (ttm)	2.9B
EPS (ttm)	R$1.57
P/E (trailing)	19.6x
P/E (forward)	12.9x
Volume	2
Beta	0.82

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 21.5B
Net income (ttm): 2.9B
EPS (ttm): R$1.57
P/E (trailing): 19.6x
P/E (forward): 12.9x
Market cap: 60.7B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E12.9

P25 n/aP50 n/aP75 n/a

Trailing P/E19.6

P25 n/aP50 n/aP75 n/a

ROE6.8

P25 n/aP50 n/aP75 n/a

ROIC5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/C1OO34 indicators

Market & fundamental data

Available fields

236

Groups with data

Currency

USD

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-12-03
Employees	15,000
Employees change	-1,000
Employees growth	-6.25%
Enterprise value	BRL 74.9B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-07-31
First seen	2026-05-10
Fiscal year end	October
Founded	1958
Industry	Medical Instruments & Supplies
Is primary listing	No
ISIN number	BRC1OOBDR003
Last earnings date	2026-09-09
Last refreshed	2026-10-29
Last stock split date	2024-02-20
Last stock split type	Forward
Market cap	BRL 60.7B
Next earnings date	2026-12-03
Price	BRL 30.72
Price currency	BRL
Sector	Healthcare
SIC code	3851
Stock price date	2026-10-23
Symbol	bvmf/C1OO34
Website	https://www.coopercos.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	42.69x
Average P/E ratio (3Y)	45.58x
Average P/E ratio (5Y)	42.39x
Earnings yield	5.1%
EV/Earnings	25.84x
EV/EBIT	25.44x
EV/EBITDA	14.11x
EV/FCF	21.73x
EV/Sales	3.29x
FCF / EV yield	4.6%
FCF yield	5.68%
Forward P/E	12.9x
Graham number	26.60321
Graham upside	-13.4%
Lynch fair value	BRL 7.34
Lynch upside	-76.11%
P/(FCF - SBC) ratio	19.65x
P/(OCF - SBC) ratio	12.4x
P/B ratio	1.43x
P/E ratio	19.62x
P/FCF ratio	17.61x
P/OCF ratio	11.55x
P/S ratio	2.82x
Price / tangible book value	3.97x
Price/EBITDA ratio	12.81x
Sector forward P/E	11.05x
Sector P/E	41.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	12.93%
EBITDA margin	22%
FCF margin	15.1%
Gross margin	65.93%
Operating margin	12.93%
Pretax margin	10.91%
Profit margin	13.46%
Profit per employee	BRL 193,324
Profitable quarters	1
Profitable years	18
Revenue per employee	BRL 1.4M
ROA	2.73%
ROA (5Y)	3.46%
ROCE	5.07%
ROE	6.84%
ROE (5Y)	14.75%
ROIC	5.03%
ROIC (5Y)	4.93%
SBC / revenue	1.66%
Tax / revenue	-2.55%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	42.4%
EPS growth (Q)	357.14%
EPS growth 10Y	8.57%
EPS growth 3Y	28.16%
EPS growth 5Y	-27.67%
EPS growth quarters	1
EPS growth years	0
FCF growth	64.6%
FCF growth (Q)	65.96%
FCF growth (QoQ)	183.2%
FCF growth 3Y	45.17%
FCF growth 5Y	5.21%
Gross profit growth	3.11%
Gross profit growth (Q)	2.88%
Gross profit growth 3Y	6.47%
Gross profit growth 5Y	7.26%
Net income growth	39.85%
Net income growth (Q)	340.29%
Net income growth 3Y	27.48%
Net income growth 5Y	-27.84%
Net income growth quarters	1
Net income growth years	0
OCF growth	26.58%
OCF growth (Q)	30.72%
OCF growth (QoQ)	86.93%
OCF growth 10Y	9.4%
OCF growth 3Y	22.36%
OCF growth 5Y	5.72%
Operating income growth	-26.25%
Operating income growth (Q)	26.35%
Operating income growth 3Y	2.36%
Operating income growth 5Y	-2.11%
Revenue growth	4.73%
Revenue growth (Q)	0.56%
Revenue growth (QoQ)	-1.41%
Revenue growth 10Y	8.33%
Revenue growth 3Y	6.43%
Revenue growth 5Y	8.29%
Revenue growth quarters	23
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -1.8B
Depreciation and amortization	BRL 2.1B
EBIT	BRL 2.8B
EBITDA	BRL 4.7B
EPS	BRL 1.57
Financing cash flow	BRL -3.3B
Free cash flow	BRL 3.4B
Free cash flow minus SBC	BRL 3.1B
Gross profit	BRL 14.2B
Income taxes	BRL -548.6M
Investing cash flow	BRL -1.8B
Net borrowing	BRL 356.8M
Net cash flow	BRL 152.5M
Net income	BRL 2.9B
Operating cash flow minus SBC	BRL 4.9B
Operating income	BRL 2.8B
Revenue	BRL 21.5B
Stock-based compensation	BRL 358.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.38
Book value per share	BRL 222.76
Debt / EBITDA	2.83
Debt / equity	0.34
Debt / FCF	4.13
Goodwill	BRL 20.9B
Interest coverage	6.14
Long-term assets	BRL 52.1B
Long-term liabilities	BRL 12B
Net cash (debt)	BRL -13.5B
Net cash / market cap	-22.17%
Net debt / EBITDA	2.84
Net debt / equity	0.32
Net debt / FCF	3.9
Piotroski F-Score	6
Property, plant and equipment	BRL 11.6B
Shareholders' equity	BRL 42.3B
Tangible book value	BRL 15.3B
Tangible book value per share	BRL 80.40
Total assets	BRL 64.4B
Total cash	BRL 786.6M
Total debt	BRL 14.2B
Total liabilities	BRL 22.1B
WACC	7.6%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.34
Current assets	BRL 12.3B
Current liabilities	BRL 10.1B
Current ratio	1.22
Inventory turnover	1.61
Net working capital	BRL 4.5B
Quick ratio	0.51
Working capital	BRL 2.1B
Working capital turnover	27.93

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	2.33%
Dividend per share	BRL 0.00
Last dividend	BRL 0.00
Shareholder yield	2.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 40.17
1D price change	0.89%
1M price change	9.87%
1M total return	9.87%
1W price change	13.02%
1W total return	13.02%
1Y price change	-23.89%
1Y return CAGR	-23.9%
1Y total return	-23.89%
20-day SMA	BRL 28.45
200-day SMA	BRL 41.40
3M price change	-17.68%
3M total return	-17.68%
3Y price change	-23.02%
3Y return CAGR	-8.35%
3Y total return	-23.02%
50-day SMA	BRL 33.34
50-day SMA vs 200-day SMA	50under200
52-week high	BRL 47.00
52-week high date	2025-12-05
52-week low	BRL 27.00
52-week low date	2026-09-10
5Y price change	-47.99%
5Y return CAGR	-12.25%
5Y total return	-47.98%
6M price change	-15.18%
6M total return	-15.18%
All-time high	BRL 61.92
All-time high date	2024-10-16
All-time low	BRL 27.00
All-time low date	2026-09-10
Average true range (ATR)	BRL 0.98
Average volume	77.1
Beta (5Y)	0.83
Change from 52-week high	-34.64%
Change from 52-week low	13.78%
Change from all-time high	-50.39%
Change from all-time low	13.78%
Change from open	0%
Day's gap	0.89%
Dollar volume	BRL 61.44
High price	BRL 30.72
Low price	BRL 30.72
Monthly RSI	39.87
Open price	BRL 30.72
Previous close	BRL 30.45
Price vs 150-day SMA	-23.52%
Price vs 20-day SMA	8%
Price vs 200-day SMA	-25.79%
Price vs 50-day SMA	-7.85%
Relative volume	0.03
RSI	51.57
Sharpe ratio	-0.06
Sortino ratio	-0
Volume	2
Weekly RSI	41.71
YTD price change	-33.29%
YTD total return	-33.29%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	188.8M
Shares change (QoQ)	-0.82%
Shares change (YoY)	-2.33%
Shares held by insiders	0.64%
Shares held by institutions	110.84%
Short ratio	2.7 days

Deeper analysis on BVMF/C1OO34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/C1OO34 report

Is a complete BVMF/C1OO34 research report available?

No complete published report is available for bvmf/C1OO34 (BVMF/C1OO34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/C1OO34 (BVMF/C1OO34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/C1OO34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/C1OO34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/C1OO34

Frequently asked questions